STOCK TITAN

Lexinfintch Hold Financials

LX
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows Lexinfintch Hold (LX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LX FY2024

LexinFintech's recent pattern is balance-sheet repair alongside a higher-margin revenue recovery that is throwing off less immediate cash.

Cash conversion weakened sharply: free cash flow was only $114M while net income stayed near $151M. With revenue and gross margin both better than the prior year, that gap makes FY2024 look more like a normalization of an unusually cash-rich cycle than an earnings surge that turned cleanly into cash.

Leverage has come down structurally over the last several years, with total liabilities reduced to $1.58B from $2.27B. Equity also built to $1.47B from $841M, which means more of the business is now supported by retained capital instead of creditor funding.

Overhead intensity improved: SG&A plus R&D fell to about 6.7% of revenue from about 10.3%. That points to better cost absorption and expense discipline as activity scaled back up, even though bottom-line margins did not expand nearly as much as gross margin did.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 43 / 100
Financial Health Score 43/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Lexinfintch Hold's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
35

Lexinfintch Hold's revenue declined 3.3% year-over-year, from $1.9B to $1.9B. This contraction results in a growth score of 35/100.

Leverage
84

Lexinfintch Hold carries a low D/E ratio of 0.05, meaning only $0.05 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
54

Lexinfintch Hold's current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
85

Lexinfintch Hold converts 24.8% of revenue into free cash flow ($466.4M). This strong cash generation earns a score of 85/100.

Piotroski F-Score Partial
6/8

Lexinfintch Hold passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
2.16x

For every $1 of reported earnings, Lexinfintch Hold generates $2.16 in operating cash flow ($516.9M OCF vs $239.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.9B
YoY-3.3%
5Y CAGR+1.1%

Lexinfintch Hold generated $1.9B in revenue in fiscal year 2025. This represents a decrease of 3.3% from the prior year.

EBITDA
N/A
Net Income
$239.8M
YoY+59.1%
5Y CAGR+21.3%

Lexinfintch Hold reported $239.8M in net income in fiscal year 2025. This represents an increase of 59.1% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
$466.4M
YoY+308.0%

Lexinfintch Hold generated $466.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 308.0% from the prior year.

Cash & Debt
$308.3M
YoY-4.4%
5Y CAGR+4.7%

Lexinfintch Hold held $308.3M in cash against $80.9M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
34.0%
YoY-1.4pp
5Y CAGR+2.8pp

Lexinfintch Hold's gross margin was 34.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.4 percentage points from the prior year.

Operating Margin
N/A
Net Margin
12.8%
YoY+5.0pp
5Y CAGR+7.6pp

Lexinfintch Hold's net profit margin was 12.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.0 percentage points from the prior year.

Return on Equity
14.0%
YoY+3.8pp
5Y CAGR+3.2pp

Lexinfintch Hold's ROE was 14.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.8 percentage points from the prior year.

Capital Allocation

R&D Spending
$85.1M
YoY+7.5%
5Y CAGR+3.2%

Lexinfintch Hold invested $85.1M in research and development in fiscal year 2025. This represents an increase of 7.5% from the prior year.

Share Buybacks
$28.9M

Lexinfintch Hold spent $28.9M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$50.5M
YoY+49.1%
5Y CAGR+30.6%

Lexinfintch Hold invested $50.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 49.1% from the prior year.

LX Income Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

LX Balance Sheet

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Total Assets $3.3B+8.7% $3.0B-6.5% $3.3B-1.3% $3.3B+0.1% $3.3B+5.8% $3.1B+12.8% $2.8B+52.3% $1.8B
Current Assets $2.6B+6.8% $2.5B-5.9% $2.6B+1.1% $2.6B-1.4% $2.6B+3.9% $2.5B+6.1% $2.4B+58.2% $1.5B
Cash & Equivalents $308.3M-4.4% $322.3M-10.4% $359.6M+70.9% $210.4M-45.5% $386.3M+57.4% $245.4M-23.2% $319.6M+93.8% $164.9M
Inventory $3.4M+12.7% $3.1M-35.3% $4.7M-39.5% $7.8M+4.2% $7.5M+3.8% $7.2M-52.9% $15.3M+84.4% $8.3M
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.6B+1.7% $1.6B-16.7% $1.9B-7.6% $2.0B+0.7% $2.0B-10.4% $2.3B+25.1% $1.8B+49.2% $1.2B
Current Liabilities $1.4B+5.2% $1.3B-24.2% $1.7B-4.1% $1.8B+13.2% $1.6B-13.2% $1.8B+30.8% $1.4B+20.7% $1.2B
Long-Term Debt $80.9M+1.0% $80.1M+8.5% $73.8M+238.6% $21.8M N/A N/A N/A N/A
Total Equity $1.7B+16.2% $1.5B+7.6% $1.4B+9.1% $1.3B-0.5% $1.3B+49.7% $841.5M-11.2% $948.0M+58.7% $597.3M
Retained Earnings $1.1B+23.5% $904.9M+11.9% $808.5M+13.9% $709.6M+7.8% $658.4M+103.2% $324.0M-39.6% $536.4M+131.7% $231.5M

LX Cash Flow Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

LX Financial Ratios

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 1.89+0.0 1.86+0.4 1.50+0.1 1.42-0.2 1.63+0.3 1.37-0.3 1.68+0.4 1.29
Debt-to-Equity 0.050.0 0.050.0 0.05+0.0 0.02-1.6 1.61-1.1 2.70+0.8 1.91-0.1 2.04
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Lexinfintch Hold (LX) reported $1.9B in total revenue for fiscal year 2025. This represents a -3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Lexinfintch Hold (LX) revenue declined by 3.3% year-over-year, from $1.9B to $1.9B in fiscal year 2025.

Yes, Lexinfintch Hold (LX) reported a net income of $239.8M in fiscal year 2025, with a net profit margin of 12.8%.

As of fiscal year 2025, Lexinfintch Hold (LX) had $308.3M in cash and equivalents against $80.9M in long-term debt.

Lexinfintch Hold (LX) had a gross margin of 34.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Lexinfintch Hold (LX) had a net profit margin of 12.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Lexinfintch Hold (LX) has a return on equity of 14.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Lexinfintch Hold (LX) generated $466.4M in free cash flow during fiscal year 2025. This represents a 308.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Lexinfintch Hold (LX) generated $516.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Lexinfintch Hold (LX) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Lexinfintch Hold (LX) invested $50.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Lexinfintch Hold (LX) invested $85.1M in research and development during fiscal year 2025.

Yes, Lexinfintch Hold (LX) spent $28.9M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Lexinfintch Hold (LX) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.

Lexinfintch Hold (LX) had a debt-to-equity ratio of 0.05 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Lexinfintch Hold (LX) had a return on assets of 7.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Lexinfintch Hold (LX) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Lexinfintch Hold (LX) has an earnings quality ratio of 2.16x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Lexinfintch Hold (LX) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top